微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | -0.69% | -184.15% | -365.38% | 119/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 0.26% | 230% | -13.33% | 110/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 0.3% | -50.82% | 165.22% | 109/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -0.46% | 95.4% | -156.1% | 106/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 0.82% | 173.33% | 510% | 111/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | -0.2% | 75.9% | -132.79% | 119/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.61% | 165.22% | 106.11% | 108/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -9.99% | -46.05% | -3430% | 126/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 0.3% | -84.92% | 136.14% | 114/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | -0.83% | -1022.22% | -460.87% | 120/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.23% | -34.29% | 103.36% | 111/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | -6.84% | 55.67% | -443.72% | 126/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 1.99% | 159.58% | 2111.11% | 106/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 0.09% | 104.5% | -74.29% | 117/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 0.35% | 130.43% | 102.27% | 107/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | -15.43% | -798.19% | -361.98% | 126/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | -3.34% | -215.97% | -67% | 104/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | -2% | -165.57% | -73.91% | 113/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | -1.15% | -344.68% | -152.04% | 99/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 2.21% | -72.58% | -23.26% | 107/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 2.88% | -61.34% | -5.57% | 87/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 3.05% | -41.68% | 548.94% | 70/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 0.47% | -39.74% | -94.17% | 95/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 8.06% | -49.88% | 8.19% | 66/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 7.45% | -32.09% | 42.45% | 42/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 5.23% | -52.15% | 570.51% | 36/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 0.78% | 2% | -95.15% | 85/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 16.08% | -33.64% | 46.58% | 19/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 10.97% | 2% | 0.37% | 22/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 10.93% | 2% | -54.89% | 12/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2016-12-31 | 24.23% | -24.91% | -24.91% | 12/160 | 6.33% | 河化股份 | 54.24% | 行业排名> |
| 2015-12-31 | 32.27% | -20.5% | -20.5% | 7/160 | 11.35% | 华东医药 | 7.2% | 行业排名> |